New Developments in Lymphoma–Newsletter

The Lymphoma Program has published the inaugural issue of the New Developments in Lymphoma Newsletter.

Please look to this space for further announcements of future newsletter issues, or sign up for advance notice of the newsletter here.

LLS Patient Education: Novel Therapeutic Options for Lymphoma, An Evening with Experts from Weill Cornell

Novel Therapeutic Options for Lymphoma:
What Every Patient Needs to Know about Ibrutinib, Idelalisib, and Other New Drug

The Leukemia & Lymphoma Society (LLS) in partnership with Weill Cornell Medical College and NewYork-Presbyterian Weill Cornell Medical Center are presenting a patient education event on Wednesday, April 30 at Weill Cornell Medical College.

Click here to register or contact Trisha Ouellette at (212) 376-4762.

Topics:

  • General overview of lymphoma
  • Clinical Trials/Select New Therapies
  • Complementary Medicine
  • Panel Discussion/Q&A

Moderators:

John Leonard, MD

Speakers:

Richard Furman, MD
Peter Martin, MD
Jia Ruan, MD

Date and Time:

Wednesday, April 30, 2014 5:30pm-8pm

Location:

The Griffis Faculty Club at Weill Cornell Medical College
521 East 68th Street (east of York Avenue)
New York, NY 10021

A light dinner will be provided

More information can be found here

Dr. Ari Melnick Discusses the Challenges of Measuring Tumor Heterogeneity

Earlier this week Dr. Ari Melnick answered another question from Targeted Oncology concerning the challenges associated with measuring tumor heterogeneity in finding new avenues for targeted therapy.